DK1341522T3 - Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling - Google Patents

Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling

Info

Publication number
DK1341522T3
DK1341522T3 DK01984822T DK01984822T DK1341522T3 DK 1341522 T3 DK1341522 T3 DK 1341522T3 DK 01984822 T DK01984822 T DK 01984822T DK 01984822 T DK01984822 T DK 01984822T DK 1341522 T3 DK1341522 T3 DK 1341522T3
Authority
DK
Denmark
Prior art keywords
microparticles
preparation
release profile
enhanced release
present
Prior art date
Application number
DK01984822T
Other languages
Danish (da)
English (en)
Inventor
Thomas Kissel
Peter Schneider
Ruland Fridrich
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000161944 external-priority patent/DE10061944A1/de
Priority claimed from DE2001118160 external-priority patent/DE10118160A1/de
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of DK1341522T3 publication Critical patent/DK1341522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01984822T 2000-12-13 2001-12-11 Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling DK1341522T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2000161944 DE10061944A1 (de) 2000-12-13 2000-12-13 Mikropartikel mit verbessertem Freisetzungsprofil
DE2001118160 DE10118160A1 (de) 2001-04-11 2001-04-11 Chitosan enthaltende Mikropartikel

Publications (1)

Publication Number Publication Date
DK1341522T3 true DK1341522T3 (da) 2006-02-13

Family

ID=26007947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01984822T DK1341522T3 (da) 2000-12-13 2001-12-11 Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling

Country Status (21)

Country Link
US (1) US20040115277A1 (ru)
EP (1) EP1341522B1 (ru)
JP (1) JP2004515527A (ru)
AT (1) ATE309788T1 (ru)
AU (2) AU3323902A (ru)
BG (1) BG107885A (ru)
BR (1) BR0116077A (ru)
CA (1) CA2431285A1 (ru)
CY (1) CY1105442T1 (ru)
CZ (1) CZ20031559A3 (ru)
DE (1) DE50108114D1 (ru)
DK (1) DK1341522T3 (ru)
EE (1) EE200300279A (ru)
ES (1) ES2250502T3 (ru)
HK (1) HK1054689A1 (ru)
HU (1) HUP0302363A3 (ru)
NO (1) NO20032657L (ru)
PL (1) PL363716A1 (ru)
RU (1) RU2291686C2 (ru)
SK (1) SK7172003A3 (ru)
WO (1) WO2002047664A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1761249A1 (en) * 2004-06-28 2007-03-14 Cornell Research Foundation, Inc. Injectable microspheres from unsaturated functionalized polyhydric alcohol esters
GB0416328D0 (en) * 2004-07-21 2004-08-25 Univ Cardiff Use of dry powder compositions for pulmonary delivery
EP1679065A1 (en) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8628701B2 (en) * 2006-10-31 2014-01-14 Xavier University Of Louisiana Method of micro-encapsulation
UA90013C2 (ru) * 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
WO2011163469A1 (en) 2010-06-23 2011-12-29 Teva Pharmaceutical Industries Ltd. Hydrated form of anti-inflammatory roflumilast-n-oxide
PL2790675T3 (pl) * 2011-12-14 2019-12-31 Abraxis Bioscience, Llc Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
US9308172B2 (en) * 2012-10-26 2016-04-12 Board Of Trustees Of Michigan State University Device and method for encapsulation of hydrophilic materials
WO2014169816A1 (zh) * 2013-04-18 2014-10-23 山东绿叶制药有限公司 戈舍瑞林缓释微球药物组合物
DK3021873T3 (en) 2013-07-18 2018-12-17 Xalud Therapeutics Inc Composition for the treatment of inflammatory joint disease
WO2015024759A1 (en) * 2013-08-21 2015-02-26 Evonik Industries Ag Process for preparing redispersible powders of water-insoluble, biodegradable polyesters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3116311B2 (ja) * 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
WO1994023699A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
CA2213906A1 (en) * 1996-09-23 1998-03-23 Dusica Maysinger Pharmaceutical composition and method for neuron rescue in ischemic stroke
KR100289471B1 (ko) * 1998-01-19 2001-09-17 김충섭 휀타닐계마취제의이식형서방성제제
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
EP1044683A1 (en) * 1999-04-15 2000-10-18 Debio Recherche Pharmaceutique S.A. One-step dispersion method for the microencapsulation of water soluble substances

Also Published As

Publication number Publication date
SK7172003A3 (en) 2004-05-04
WO2002047664A3 (de) 2002-12-27
CZ20031559A3 (cs) 2004-03-17
HK1054689A1 (en) 2003-12-12
JP2004515527A (ja) 2004-05-27
HUP0302363A3 (en) 2006-07-28
ES2250502T3 (es) 2006-04-16
ATE309788T1 (de) 2005-12-15
AU3323902A (en) 2002-06-24
RU2291686C2 (ru) 2007-01-20
EP1341522A2 (de) 2003-09-10
PL363716A1 (en) 2004-11-29
EP1341522B1 (de) 2005-11-16
WO2002047664A2 (de) 2002-06-20
EE200300279A (et) 2003-10-15
NO20032657L (no) 2003-07-18
US20040115277A1 (en) 2004-06-17
WO2002047664A8 (de) 2004-03-04
DE50108114D1 (de) 2005-12-22
CA2431285A1 (en) 2002-06-20
NO20032657D0 (no) 2003-06-12
BR0116077A (pt) 2004-02-17
HUP0302363A2 (hu) 2003-10-28
CY1105442T1 (el) 2010-04-28
AU2002233239B2 (en) 2006-05-11
BG107885A (bg) 2004-01-30

Similar Documents

Publication Publication Date Title
DE60135872D1 (de) Absackbekämpfung bei isorohren, die bei der herstellung von flachglas nach dem schmelzverfahren verwendet werden
MX249034B (es) Amidinas de tiofeno novedosas, composiciones de las mismas, y metodos para tratar enfermedades y condiciones mediadas por el complemento.
WO2008107149A3 (de) Darreichungsform mit erschwertem missbrauch
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
WO2001079460A3 (en) Polypeptides having haloperoxidase activity
DE60231395D1 (de) Dezellularisierung von gewebematrixen
DK1341522T3 (da) Mikropartikler med forbedret frigivelsesprofil og Fremgangsmåde til deres fremstilling
HK1067544A1 (en) Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
YU31000A (sh) Sferoidi, postupak za dobijanje i farmaceutske kompozicije
DK1399133T4 (da) Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
FR2894143B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
GB0216002D0 (en) Process and composition
GB0004827D0 (en) Compositions
ITMI20001093A0 (it) Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse.
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
HRP20050055B1 (hr) Mikrokapsule za odloženo i kontrolirano oslobađanje perindoprila
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
AU2003302188A8 (en) Method of obtaining a soothing active ingredient, active ingredient and compositions obtained
WO2004017938A3 (en) Nitrofurantoin controlled release dosage form